The present invention relates in particular to antisense oligonucleotides that modulate the expression and / or function of fibroblast growth factor 21 (FGF21) by targeting natural antisense polynucleotides of fibroblast growth factor 21 (FGF21). The invention also relates to the identification of these antisense oligonucleotides and their use in the treatment of diseases and disorders associated with the expression of fibroblast growth factor 21 (FGF21).
展开▼
